THOMSON MEDICAL GROUP LIMITED
Change - Announcement of Appointment::Re-designation of Non-Executive to Executive Director
Issuer & Securities
Issuer/ ManagerTHOMSON MEDICAL GROUP LIMITEDSecuritiesTHOMSON MED S$225M4.8%N220718 - SGXF90488481 - YRYB
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled SecurityNo
Announcement Details
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled SecurityNo
Announcement Title Change - Announcement of AppointmentDate &Time of Broadcast 01-Dec-2021 17:54:51Status NewAnnouncement Sub TitleRe-designation of Non-Executive to Executive DirectorAnnouncement ReferenceSG211201OTHRXJU0Submitted By (Co./ Ind. Name)Lim Hoi LeongDesignationCompany SecretaryDescription (Please provide a detailed description of the event in the box below)Re-designation of Lim Wee Kiat from Non-Executive to Executive Director with effect from 1 January 2022.
Additional Details
Date Of Appointment01/01/2022Name Of PersonLim Wee KiatAge28Country Of Principal ResidenceSingaporeDate of last re-appointment (if applicable)22/10/2021The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)The Nominating and Remuneration Committee (NRC) of the Company, having reviewed Mr Lim's start-up experience and his contributions to the Group's technology roadmap, has recommended to the Board that Mr Lim will be appointed as the CEO of Thomson X and accordingly will be re-designated from his existing position as Non-Executive Director to Executive Director with effect from 1 Jan 2022.
As a CEO of Thomson X, Mr Lim will lead and drive new growth areas in healthtech solutions through synergistic partnership and investment opportunities for the Group.
The Board has reviewed and approved the appointment of Mr Lim as CEO of Thomson X and the re-designation of his role to Executive Director of the Company.
Following his appointment and re-designation, Mr Lim will relinquish his role as a member of NRC of the Company. Whether appointment is executive, and if so, the area of responsibilityExecutive
Lead and drive new growth areas in healthtech solutions through synergistic partnership and investment opportunities for the Group. Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)Executive Director
CEO of Thomson XProfessional qualificationsBachelor of Science in Psychology from University of New South Wales, Australia Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiariesMr Lim is the son of the controlling shareholder, Mr Lim Eng Hock. Conflict of interests (including any competing business)NoWorking experience and occupation(s) during the past 10 years2017 - 2020
Vice President, Investment
Kestrel Capital Pte Ltd Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))YesShareholding interest in the listed issuer and its subsidiaries?No# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).Past (for the last 5 years)Director
- Catpital Private Limited PresentDirector
- Thomson X Pte Ltd
- Towerhill Pte Ltd
- Selectstart Pte Ltd
- SL8 Pte Ltd
- Kelarc Pte Ltd
- RSP Holdings Pte Ltd
- RSP Topco Pte Ltd
- ZujuGP Pte Ltd
- Zuju Gameplay Pte Ltd
- Klouder Limited
Principal Commitment
- Vice President and Board member of Singapore ESports Association(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?No(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?No(c) Whether there is any unsatisfied judgment against him?No(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?No(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?No(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?No(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?No(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?No(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?No(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; orNo(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; orNo(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; orNo(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?No(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?NoAny prior experience as a director of an issuer listed on the Exchange?YesIf Yes, Please provide details of prior experienceMr Lim is the existing director of Thomson Medical Group Limited
Related Announcements
As a CEO of Thomson X, Mr Lim will lead and drive new growth areas in healthtech solutions through synergistic partnership and investment opportunities for the Group.
The Board has reviewed and approved the appointment of Mr Lim as CEO of Thomson X and the re-designation of his role to Executive Director of the Company.
Following his appointment and re-designation, Mr Lim will relinquish his role as a member of NRC of the Company. Whether appointment is executive, and if so, the area of responsibilityExecutive
Lead and drive new growth areas in healthtech solutions through synergistic partnership and investment opportunities for the Group. Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)Executive Director
CEO of Thomson XProfessional qualificationsBachelor of Science in Psychology from University of New South Wales, Australia Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiariesMr Lim is the son of the controlling shareholder, Mr Lim Eng Hock. Conflict of interests (including any competing business)NoWorking experience and occupation(s) during the past 10 years2017 - 2020
Vice President, Investment
Kestrel Capital Pte Ltd Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))YesShareholding interest in the listed issuer and its subsidiaries?No# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).Past (for the last 5 years)Director
- Catpital Private Limited PresentDirector
- Thomson X Pte Ltd
- Towerhill Pte Ltd
- Selectstart Pte Ltd
- SL8 Pte Ltd
- Kelarc Pte Ltd
- RSP Holdings Pte Ltd
- RSP Topco Pte Ltd
- ZujuGP Pte Ltd
- Zuju Gameplay Pte Ltd
- Klouder Limited
Principal Commitment
- Vice President and Board member of Singapore ESports Association(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?No(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?No(c) Whether there is any unsatisfied judgment against him?No(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?No(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?No(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?No(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?No(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?No(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?No(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; orNo(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; orNo(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; orNo(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?No(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?NoAny prior experience as a director of an issuer listed on the Exchange?YesIf Yes, Please provide details of prior experienceMr Lim is the existing director of Thomson Medical Group Limited
Related Announcements
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Thomson Medical Group Ltd. published this content on 01 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 December 2021 10:00:10 UTC.
